Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.10 USD
Change Today -0.06 / -2.78%
Volume 107.5K
KBIO On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 5:20 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

R. Andrew McMillan Ph.D.

Former Board Observer, KaloBios Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 31 board members in 3 different organizations across 6 different industries.

See Board Relationships
----

Background*

Dr. R. Andrew McMillan, Ph.D. serves as a Board Observer of Ambrx Inc., Antipodean Pharmaceuticals Inc., KaloBios Inc. and Pearl Therapeutics Inc. Dr. McMillan serves as a Director of Wildcat Discovery Technologies, Inc. He serves as a Board Observer of Achaogen Inc. Dr. McMillan was a Principal at 5AM Ventures since February 20, 2008. He served as a Board Observer of KaloBios Pharmaceuticals, Inc. He joined 5AM Ventures in 2005 as a Senior Associate. Dr. McMillan was ...

Read Full Background

Corporate Headquarters*

442 Littlefield Avenue
South San Francisco, California 94080

United States

Phone: 650-243-3100
Fax: --

Board Members Memberships*

Board Observer
Director
Board Observer

Education*

BS
University Of North Carolina At Chapel Hill
PhD
Emory University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KBIO:US $2.10 USD -0.06

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KALOBIOS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.